Picture of Instem logo

INS Instem Share Price

0.000.00%
gb flag iconLast trade - 00:00
TechnologyAdventurousSmall CapHigh Flyer

Momentum

Relative Strength (%)
1m+10.88%
3m+31.58%
6m+34.32%
1yr+21.12%
Volume Change (%)
10d/3m-79.51%
Price vs... (%)
52w High-0.67%
50d MA+3.1%
200d MA+21.71%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)21.57
PEG Ratio (f)0.97
EPS Growth (f)28.44%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value3.65
Price to Tang. Bookn/a
Price to Free Cashflow43.87
Price to Sales3.31
EV to EBITDA20.57

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital9.13%
Return on Equity6.45%
Operating Margin8.79%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total Revenue£m22.725.7228.2246.0257.636573.422.29%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+100.33-28.65+74.11-36.9+154.06+34.59+27.83n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Instem EPS forecast chart

Profile Summary

Instem plc is a United Kingdom-based company that is a provider of information technology (IT) solutions to the global life sciences market. The Company operates through four segments: Study Management, Regulatory Solutions, In Silico Solutions and Clinical Trial Acceleration. Study Management Solutions offers software that enables organizations to collect, review, manage and report discovery and preclinical data. Regulatory Solutions provides software, outsourced services and consulting for managing, storing, sharing, submitting and maintaining information compliant with agency regulations. The Company's In Silico Solutions enable researchers to generate scientific insights through the identification, extraction and analysis of information. Clinical Trials Acceleration Solutions offers technology solutions and consulting services to facilitate data integration, statistics, analytics and insights for companies of any size or stage of clinical trial analysis.

Directors

Last Annual
December 31st, 2022
Last Interim
June 30th, 2023
Incorporated
February 5th, 2010
Public Since
October 13th, 2010
No. of Employees
493
Sector
Software & IT Services
Industry
Technology
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
24,053,390

INS Share Price Performance

Upcoming Events for INS

Full Year 2023 Instem PLC Earnings Release

Similar to INS

Picture of 1Spatial logo

1Spatial

gb flag iconLondon Stock Exchange

Picture of 4Global logo

4Global

gb flag iconLondon Stock Exchange

Picture of Access Intelligence logo

Access Intelligence

gb flag iconLondon Stock Exchange

Picture of accesso Technology logo

accesso Technology

gb flag iconLondon Stock Exchange

Picture of Activeops logo

Activeops

gb flag iconLondon Stock Exchange

FAQ